SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001239241-19-000001
Filing Date
2019-10-04
Accepted
2019-10-04 17:33:26
Documents
1
Period of Report
2019-10-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5454
  Complete submission text file 0001239241-19-000001.txt   6849
Mailing Address C/O VENROCK ASSOCIATES 7 BRYANT PARK, 23RD FLOOR NEW YORK NY 10018
Business Address
EVNIN ANTHONY B (Reporting) CIK: 0001239241 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38584 | Film No.: 191139295

Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Issuer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations